Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Karyopharm Therapeutics (KPTI) Change in Accured Expenses (2016 - 2025)

Karyopharm Therapeutics' Change in Accured Expenses history spans 14 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 77.67% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $19.1 million, up 353.77%, while the annual FY2025 figure was $19.1 million, 353.77% up from the prior year.
  • Change in Accured Expenses reached $1.4 million in Q4 2025 per KPTI's latest filing, down from $9.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $12.1 million in Q3 2021 to a low of -$9.4 million in Q1 2023.
  • Average Change in Accured Expenses over 5 years is $1.7 million, with a median of $2.3 million recorded in 2022.
  • Peak YoY movement for Change in Accured Expenses: plummeted 373.51% in 2022, then surged 14957.89% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $3.7 million in 2021, then plummeted by 43.34% to $2.1 million in 2022, then surged by 129.16% to $4.8 million in 2023, then soared by 35.08% to $6.5 million in 2024, then crashed by 77.67% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for KPTI's Change in Accured Expenses are $1.4 million (Q4 2025), $9.5 million (Q3 2025), and $8.6 million (Q2 2025).